BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14530350)

  • 21. A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice.
    Pajon R; Buckwalter CM; Johswich KO; Gray-Owen SD; Granoff DM
    Vaccine; 2015 Mar; 33(11):1317-1323. PubMed ID: 25662856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of phenotypically indistinguishable but geographically distinct Neisseria meningitidis Group B isolates in a serum bactericidal antibody assay.
    Findlow J; Holland A; Andrews N; Weynants V; Sotolongo F; Balmer P; Poolman J; Borrow R
    Clin Vaccine Immunol; 2007 Nov; 14(11):1451-7. PubMed ID: 17881507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Murine monoclonal antibodies to PorA of Neisseria meningitidis show reduced protective activity in vivo against B:15:P1.7,16 subtype variants in an infant rat infection model.
    Toropainen M; Saarinen L; van der Ley P; Kuipers B; Käyhty H
    Microb Pathog; 2001 Mar; 30(3):139-48. PubMed ID: 11273739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003.
    Mueller JE; Yaro S; Traore Y; Sangare L; Tarnagda Z; Njanpop-Lafourcade BM; Borrow R; Gessner BD
    J Infect Dis; 2006 Mar; 193(6):812-20. PubMed ID: 16479516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac.
    Findlow J; Taylor S; Aase A; Horton R; Heyderman R; Southern J; Andrews N; Barchha R; Harrison E; Lowe A; Boxer E; Heaton C; Balmer P; Kaczmarski E; Oster P; Gorringe A; Borrow R; Miller E
    Infect Immun; 2006 Aug; 74(8):4557-65. PubMed ID: 16861642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outer membrane vesicles extracted from Neisseria meningitidis serogroup X for prevention of meningococcal disease in Africa.
    Acevedo R; Zayas C; Norheim G; Fernández S; Cedré B; Aranguren Y; Cuello M; Rodriguez Y; González H; Mandiarote A; Pérez M; Hernández M; Hernández-Cedeño M; González D; Brorson SH; Rosenqvist E; Naess L; Tunheim G; Cardoso D; García L
    Pharmacol Res; 2017 Jul; 121():194-201. PubMed ID: 28495657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning, expression and purification of outer membrane protein PorA of Neisseria meningitidis serogroup B.
    Haghi F; Peerayeh SN; Siadat SD; Montajabiniat M
    J Infect Dev Ctries; 2011 Dec; 5(12):856-62. PubMed ID: 22169784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies for development of universal vaccines against meningococcal serogroup B disease: the most promising options and the challenges evaluating them.
    Holst J
    Hum Vaccin; 2007; 3(6):290-4. PubMed ID: 17712231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human antibody and memory B and T-cell responses after primary and booster immunisation against Neisseria meningitidis B.
    Cruz SC; Souza SL; Cruz AC; Silva GP; Milagres LG
    Vaccine; 2011 Oct; 29(43):7387-94. PubMed ID: 21803107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multivalent liposome-based vaccines containing different serosubtypes of PorA protein induce cross-protective bactericidal immune responses against Neisseria meningitidis.
    Humphries HE; Williams JN; Blackstone R; Jolley KA; Yuen HM; Christodoulides M; Heckels JE
    Vaccine; 2006 Jan; 24(1):36-44. PubMed ID: 16105711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence of Antibody-Mediated, Complement-Dependent Opsonophagocytic Activity against Neisseria meningitidis Serogroup B in England.
    Humphries HE; Brookes C; Allen L; Kuisma E; Gorringe A; Taylor S
    Clin Vaccine Immunol; 2015 May; 22(5):503-9. PubMed ID: 25739917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rates of detection of Neisseria meningitidis in tonsils differ in relation to local incidence of invasive disease.
    Greiner O; Berger C; Day PJ; Meier G; Tang CM; Nadal D
    J Clin Microbiol; 2002 Nov; 40(11):3917-21. PubMed ID: 12409352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serological correlates of protection against meningococci in a cohort of university students, before and during an outbreak of serogroup C infection.
    Williams JN; Jones GR; Christodoulides M; Heckels JE
    J Infect Dis; 2003 May; 187(9):1433-41. PubMed ID: 12717625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant outer membrane secretin PilQ(406-770) as a vaccine candidate for serogroup B Neisseria meningitidis.
    Haghi F; Peerayeh SN; Siadat SD; Zeighami H
    Vaccine; 2012 Feb; 30(9):1710-4. PubMed ID: 22234267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitidis.
    Weynants VE; Feron CM; Goraj KK; Bos MP; Denoël PA; Verlant VG; Tommassen J; Peak IR; Judd RC; Jennings MP; Poolman JT
    Infect Immun; 2007 Nov; 75(11):5434-42. PubMed ID: 17664268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel mimetic antigen eliciting protective antibody to Neisseria meningitidis.
    Granoff DM; Moe GR; Giuliani MM; Adu-Bobie J; Santini L; Brunelli B; Piccinetti F; Zuno-Mitchell P; Lee SS; Neri P; Bracci L; Lozzi L; Rappuoli R
    J Immunol; 2001 Dec; 167(11):6487-96. PubMed ID: 11714816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870.
    Hou VC; Koeberling O; Welsch JA; Granoff DM
    J Infect Dis; 2005 Aug; 192(4):580-90. PubMed ID: 16028126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine.
    Bai X; Borrow R
    Expert Rev Vaccines; 2010 Oct; 9(10):1203-17. PubMed ID: 20923270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parenteral influenza vaccination influences mucosal and systemic T cell-mediated immunity in healthy adults.
    Guthrie T; Hobbs CG; Davenport V; Horton RE; Heyderman RS; Williams NA
    J Infect Dis; 2004 Dec; 190(11):1927-35. PubMed ID: 15529256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B
    Mulhall RM; Bennett D; Cunney R; Borrow R; Lucidarme J; Findlow J; Jolley KA; Bray J; Maiden MCJ; Moschioni M; Serino L; Stella M; Medini D
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30135218
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.